SHANGHAI, Aug. 9, 2013 /PRNewswire/ -- Newly improved delivery systems for primary available drugs are not only beneficial for patients but also less complicated while offering needle-free delivery and a reduction in the dose of active ingredients. According to statistics, the global Drug Delivery Systems market is projected to reach $196.4 billion by 2014. And the global injectable drug delivery market is expected to be worth $29.981 billion by 2015. Therefore, huge market opportunities and challenges exist at the same time in NDDS, both for pharma manufacturers and NDDS suppliers.
(Photo: http://www.prnasia.com/sa/2013/08/08/20130808104651412059.html)
Organized by CPhI and UBM Conferences, both NDDS 2011 & 2012 were successful in offering a platform for the NDDS industry to network and learn, in addition both forums were highly regarded by the attending delegates. The 3rd NDDS & Clinical Trial Management China 2013 will take place on 27th-28th November at the Crowne Plaza Century Park, Shanghai. This year's edition will deliver themes which will drive cross-industry co-operation, engage in learning about the latest market trends and advancements in both technique and methodology, and to provide a business network environment to the unique participants of this conference. The two-day conference will include 3 chapters: Drug discovery and research fulfillments, Novel pathways for future drug delivery solutions and Biotherapeutic drug delivery towards clinical science development. There will be 16 professional presentations and 2 panel discussions exploring the commercial value, techniques, requirements and clinical science of NDDS. To download the full agenda, please visit www.ndds-china.com.
If you have any questions, please call +86-21-61573930 or send an email to [email protected].
Media Contact
Ms. Tracy Cui
Tel: +86-21-6157 3919
Fax:+86-21-6157 7299
Email: [email protected]
SOURCE UBM Conferences
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article